{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:35:44Z","timestamp":1788280544393,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2024CXA028"],"award-info":[{"award-number":["2024CXA028"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2024GGA023"],"award-info":[{"award-number":["2024GGA023"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.canlet.2026.218303","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:05:26Z","timestamp":1770397526000},"page":"218303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Treg-driven magnetic resonance radiomics in glioblastoma: a multicenter and cross-species model for prognostic biomarker discovery"],"prefix":"10.1016","volume":"642","author":[{"given":"Xuezhen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyuan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinkai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qichun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsheng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1800-7505","authenticated-orcid":false,"given":"Mingwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2026.218303_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","article-title":"Glioblastoma at the crossroads: current understanding and future therapeutic horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218303_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216711","article-title":"Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: a multicentric retrospective study","volume":"588","author":"Miele","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2026.218303_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12885-022-10492-9","article-title":"The prognostic significance of tumor-associated neutrophils and circulating neutrophils in glioblastoma (WHO CNS5 classification)","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218303_bib4","article-title":"The prognostic value and biological significance of MRI CE-T1-based radiomics models in CNS5-identified GBM: a multi-center study","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.canlet.2026.218303_bib5","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218303_bib6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.trecan.2020.02.010","article-title":"MGMT status as a clinical biomarker in glioblastoma","volume":"6","author":"Butler","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.canlet.2026.218303_bib7","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejca.2021.01.014","article-title":"Telomerase reverse transcriptase promoter mutation- and O(6)-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?","volume":"147","author":"Gramatzki","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2026.218303_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14720","article-title":"Advanced tumor electric fields therapy: a review of innovative research and development and prospect of application in glioblastoma","volume":"30","author":"Lan","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.canlet.2026.218303_bib9","first-page":"228","article-title":"Biomimetic extracellular vesicles derived from chimeric antigen receptor monocytes to treat glioblastoma: an efficient and safe intranasal drug delivery nanoplatform","volume":"52","author":"Cheng","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.canlet.2026.218303_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217601","article-title":"Advancing glioblastoma therapy: learning from the past and innovations for the future","volume":"617","author":"Rana","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218303_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217805","article-title":"Aberrant PLAC8 expression characterizes glioblastoma with temozolomide resistance and an immunosuppressive microenvironment","volume":"625","author":"She","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218303_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101115","article-title":"Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma","volume":"76","author":"Hong","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.canlet.2026.218303_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216594","article-title":"Deciphering the immune modulation through deep transcriptomic profiling and therapeutic implications of DNA damage repair pattern in hepatocellular carcinoma","volume":"582","author":"Hong","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2026.218303_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.canlet.2026.218303_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trecan.2022.09.005","article-title":"Challenges in glioblastoma research: focus on the tumor microenvironment","volume":"9","author":"Bikfalvi","year":"2023","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2026.218303_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000826","article-title":"Combination of radiotherapy and suppression of tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer","volume":"8","author":"Ji","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.canlet.2026.218303_bib17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41568-023-00576-4","article-title":"Advances in PET imaging of cancer","volume":"23","author":"Schwenck","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.canlet.2026.218303_bib18","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/neuonc\/noaa121","article-title":"Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions","volume":"22","author":"Di Stefano","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218303_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216380","article-title":"Noninvasive radiomics model reveals macrophage infiltration in glioma","volume":"573","author":"Fan","year":"2023","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.canlet.2026.218303_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1148\/radiol.2021202553","article-title":"The biological meaning of radiomic features","volume":"298","author":"Tomaszewski","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.canlet.2026.218303_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105789","article-title":"Multimodal data integration for biologically-relevant artificial intelligence to guide adjuvant chemotherapy in stage II colorectal cancer","volume":"117","author":"Xie","year":"2025","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.canlet.2026.218303_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04503-2020","article-title":"Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis","volume":"59","author":"Schniering","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.canlet.2026.218303_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.158","article-title":"The REMBRANDT study, a large collection of genomic data from brain cancer patients","volume":"5","author":"Gusev","year":"2018","journal-title":"Sci. Data"},{"issue":"7","key":"10.1016\/j.canlet.2026.218303_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2026.218303_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cmpb.2019.05.023","article-title":"Evaluate cutpoints: adaptable continuous data distribution system for determining survival in kaplan-meier estimator","volume":"177","author":"Og\u0142uszka","year":"2019","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"10.1016\/j.canlet.2026.218303_bib26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12967-024-05313-5","article-title":"Unveiling novel cell clusters and biomarkers in glioblastoma and its peritumoral microenvironment at the single-cell perspective","volume":"22","author":"Wang","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.canlet.2026.218303_bib27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41467-022-28372-y","article-title":"Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target","volume":"13","author":"Abdelfattah","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2026.218303_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12943-023-01860-5","article-title":"Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.canlet.2026.218303_bib29","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.immuni.2025.02.022","article-title":"Single-cell atlas of endothelial and mural cells across primary and metastatic brain tumors","volume":"58","author":"Bejarano","year":"2025","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.canlet.2026.218303_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13062-025-00640-z","article-title":"Large-scale bulk and single-cell RNA sequencing combined with machine learning reveals glioblastoma-associated neutrophil heterogeneity and establishes a VEGFA(+) neutrophil prognostic model","volume":"20","author":"Yang","year":"2025","journal-title":"Biol. Direct"},{"issue":"21","key":"10.1016\/j.canlet.2026.218303_bib31","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.canlet.2026.218303_bib32","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1158\/0008-5472.CAN-22-1183","article-title":"Images are data: challenges and opportunities in the clinical translation of radiomics","volume":"82","author":"Mu","year":"2022","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.canlet.2026.218303_bib33","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.spinee.2024.02.021","article-title":"Spine-specific sarcopenia: distinguishing paraspinal muscle atrophy from generalized sarcopenia","volume":"24","author":"Sch\u00f6nnagel","year":"2024","journal-title":"Spine J."},{"issue":"1","key":"10.1016\/j.canlet.2026.218303_bib34","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1038\/s41467-021-22885-8","article-title":"Targeting treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas","volume":"12","author":"Amoozgar","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.canlet.2026.218303_bib35","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/cas.14069","article-title":"Regulatory T (treg) cells in cancer: can treg cells be a new therapeutic target?","volume":"110","author":"Ohue","year":"2019","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.canlet.2026.218303_bib36","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4049\/jimmunol.179.2.977","article-title":"Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response","volume":"179","author":"Sinha","year":"2007","journal-title":"J. Immunol."},{"issue":"5899","key":"10.1016\/j.canlet.2026.218303_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.canlet.2026.218303_bib38","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/jnci\/djz036","article-title":"STAT3 modulation of regulatory T cells in response to radiation therapy in head and neck cancer","volume":"111","author":"Oweida","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.canlet.2026.218303_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001955","article-title":"Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis","volume":"9","author":"Knitz","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2026.218303_bib40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s43018-023-00547-6","article-title":"CD103(+) regulatory T cells underlie resistance to radio-immunotherapy and impair CD8(+) T cell activation in glioblastoma","volume":"4","author":"van Hooren","year":"2023","journal-title":"Nat. Cancer"},{"issue":"19","key":"10.1016\/j.canlet.2026.218303_bib41","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1158\/1078-0432.CCR-23-3616","article-title":"Targeting the dendritic cell-secreted immunoregulatory cytokine CCL22 alleviates radioresistance","volume":"30","author":"Bugno","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.canlet.2026.218303_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71027","article-title":"TWEAK\/Fn14 drives tumor progression and is associated with poor survival of colorectal liver metastases with replacement growth patterns","volume":"14","author":"Matsuyama","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2026.218303_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2025.110328","article-title":"PPIA enhances cell growth and metastasis through CD147 in oral cancer","volume":"765","author":"Liao","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.canlet.2026.218303_bib44","article-title":"Galectin-3 in tumor-stromal cells enhances gemcitabine resistance in pancreatic adenocarcinoma by suppressing oxidative phosphorylation","volume":"12","author":"Wu","year":"2025","journal-title":"Genes Dis."},{"issue":"888","key":"10.1016\/j.canlet.2026.218303_bib45","article-title":"YAP controls cell migration and invasion through a rho GTPase switch","volume":"18","author":"Shah","year":"2025","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2026.218303_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117704","article-title":"Identification of a new small rho GTPase inhibitor effective in glioblastoma human cells","volume":"292","author":"Parise","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2026.218303_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12967-023-04823-y","article-title":"Immune-related lncRNAs signature and radiomics signature predict the prognosis and immune microenvironment of glioblastoma multiforme","volume":"22","author":"Luan","year":"2024","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.canlet.2026.218303_bib48","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","article-title":"A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study","volume":"19","author":"Sun","year":"2018","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2026.218303_bib49","doi-asserted-by":"crossref","first-page":"469","DOI":"10.21037\/atm.2020.03.114","article-title":"A CT-based radiomics signature for evaluating tumor infiltrating treg cells and outcome prediction of gastric cancer","volume":"8","author":"Gao","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"24","key":"10.1016\/j.canlet.2026.218303_bib50","doi-asserted-by":"crossref","first-page":"21861","DOI":"10.1002\/cam4.6757","article-title":"Profiling regulatory T lymphocytes within the tumor microenvironment of breast cancer via radiomics","volume":"12","author":"Jiang","year":"2023","journal-title":"Cancer Med."},{"issue":"24","key":"10.1016\/j.canlet.2026.218303_bib51","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1158\/1078-0432.CCR-17-3420","article-title":"A coclinical radiogenomic validation study: conserved magnetic resonance radiomic appearance of periostin-expressing glioblastoma in patients and xenograft models","volume":"24","author":"Zinn","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2026.218303_bib52","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.radonc.2015.06.013","article-title":"Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells","volume":"116","author":"Panth","year":"2015","journal-title":"Radiother. Oncol."},{"issue":"6","key":"10.1016\/j.canlet.2026.218303_bib53","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41591-023-02345-0","article-title":"Intratumoral dendritic cell-CD4(+) T helper cell niches enable CD8(+) T cell differentiation following PD-1 blockade in hepatocellular carcinoma","volume":"29","author":"Magen","year":"2023","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.canlet.2026.218303_bib54","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00259-016-3541-z","article-title":"Hypoxic glucose metabolism in glioblastoma as a potential prognostic factor","volume":"44","author":"Toyonaga","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.canlet.2026.218303_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95980-x","article-title":"Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis","volume":"11","author":"Wen","year":"2021","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.canlet.2026.218303_bib56","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","article-title":"Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IkappaBalpha","volume":"34","author":"Guo","year":"2022","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.canlet.2026.218303_bib57","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1038\/s41467-021-26180-4","article-title":"DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218303_bib58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2051-1426-2-10","article-title":"Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients","volume":"2","author":"Everson","year":"2014","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.canlet.2026.218303_bib59","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1158\/1078-0432.CCR-15-0858","article-title":"B7-H4(B7x)-Mediated cross-talk between glioma-initiating cells and macrophages via the IL6\/JAK\/STAT3 pathway lead to poor prognosis in glioma patients","volume":"22","author":"Yao","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2026.218303_bib60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/intimm\/dxad035","article-title":"Metabolic advantages of regulatory T cells dictated by cancer cells","volume":"36","author":"Kondo","year":"2024","journal-title":"Int. Immunol."},{"issue":"16","key":"10.1016\/j.canlet.2026.218303_bib61","doi-asserted-by":"crossref","first-page":"384","DOI":"10.21037\/atm.2019.07.45","article-title":"Immunoregulatory role of IL-2\/STAT5\/CD4+CD25+Foxp3 treg pathway in the pathogenesis of chronic osteomyelitis","volume":"7","author":"Mao","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"7","key":"10.1016\/j.canlet.2026.218303_bib62","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1002\/ptr.8222","article-title":"Salvianolic acid B alleviates autoimmunity in Treg-deficient mice via inhibiting IL2-STAT5 signaling","volume":"38","author":"Wang","year":"2024","journal-title":"Phytother Res."},{"issue":"9","key":"10.1016\/j.canlet.2026.218303_bib63","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00262-021-02872-0","article-title":"Regulatory T cells promote glioma cell stemness through TGF-beta-NF-kappaB-IL6-STAT3 signaling","volume":"70","author":"Liu","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.canlet.2026.218303_bib64","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.transproceed.2019.04.067","article-title":"Rapamycin modulate Treg\/Th17 balance via regulating metabolic pathways: a study in mice","volume":"51","author":"Zhang","year":"2019","journal-title":"Transplant. Proc."},{"issue":"19","key":"10.1016\/j.canlet.2026.218303_bib65","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1158\/1078-0432.CCR-19-3874","article-title":"Advanced Age increases immunosuppression in the brain and decreases immunotherapeutic efficacy in subjects with glioblastoma","volume":"26","author":"Ladomersky","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218303_bib66","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13046-024-03175-9","article-title":"The dual role of POSTN in maintaining glioblastoma stem cells and the immunosuppressive phenotype of microglia in glioblastoma","volume":"43","author":"Wang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218303_bib67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13578-023-00961-4","article-title":"Predictive biomarkers for the responsiveness of recurrent glioblastomas to activated killer cell immunotherapy","volume":"13","author":"Hwang","year":"2023","journal-title":"Cell Biosci."},{"issue":"5","key":"10.1016\/j.canlet.2026.218303_bib68","first-page":"1141","article-title":"Genetic profile, PTEN mutation and therapeutic role of PTEN in glioblastomas","volume":"21","author":"Fan","year":"2002","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.canlet.2026.218303_bib69","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00262-024-03774-7","article-title":"Predicting recurrent glioblastoma clinical outcome to immune checkpoint inhibition and low-dose bevacizumab with tumor in situ fluid circulating tumor DNA analysis","volume":"73","author":"Guo","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.canlet.2026.218303_bib70","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1158\/0008-5472.CAN-14-2004","article-title":"A urokinase receptor-bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma","volume":"75","author":"Wykosky","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218303_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216834","article-title":"OH2 oncolytic virus: a novel approach to glioblastoma intervention through direct targeting of tumor cells and augmentation of anti-tumor immune responses","volume":"589","author":"Zheng","year":"2024","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.canlet.2026.218303_bib72","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ni.3076","article-title":"Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses","volume":"16","author":"Shrestha","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2026.218303_bib73","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2018.01.017","article-title":"MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer","volume":"418","author":"Fan","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218303_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110091","article-title":"MUC1 induces the accumulation of Foxp3(+) treg cells in the tumor microenvironment to promote the growth and metastasis of cholangiocarcinoma through the EGFR\/PI3K\/Akt signaling pathway","volume":"118","author":"Zhang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"40","key":"10.1016\/j.canlet.2026.218303_bib75","doi-asserted-by":"crossref","first-page":"21085","DOI":"10.1074\/jbc.M116.717892","article-title":"Amphiregulin confers regulatory T cell suppressive function and tumor invasion via the EGFR\/GSK-3beta\/Foxp3 axis","volume":"291","author":"Wang","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218303_bib76","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6079957","article-title":"Construction of a TTN mutation-based prognostic model for evaluating immune microenvironment, cancer stemness, and outcomes of colorectal cancer patients","volume":"2023","author":"Zhao","year":"2023","journal-title":"Stem Cells Int"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T03:10:53Z","timestamp":1772075453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":76,"alternative-id":["S0304383526000662"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218303","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treg-driven magnetic resonance radiomics in glioblastoma: a multicenter and cross-species model for prognostic biomarker discovery","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218303"}}